The company said the item expects a revenue of between $9.65 billion as well as $9.80 billion as well as adjusted earnings per share of $1.35 to $1.39 in 2018.

Analysts on average forecast earnings per share of $1.38 on a revenue of $9.61 billion in 2018, according to Thomson Reuters I/B/E/S.

Boston Scientific reported a net loss of $615 million, or 45 cents per share, inside fourth quarter ended Dec. 31, compared using a profit of $124 million, or 9 cents per share, a year earlier. inside reporting quarter, the company incurred a $842 million charge due to adjustments inside U.S. tax law.

The company’s adjusted earnings of 34 cents per share were in line with the average analyst estimate.